Current stage?-Stage I - Page 9 of 24 Posts on Medivizor
Navigation Menu

Current stage?-Stage I Posts on Medivizor

Erectile function and focal therapy

Erectile function and focal therapy

Posted by on Nov 30, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined erectile function following treatment of prostate cancer with focal therapy. Researchers reported a return of erectile function from 6 months after focal therapy. Some background Surgery and radiation are first-line treatments for localized (confined) prostate cancer. In some cases, focal therapies are recommended...

Read More

Primary prostate cancer treatment improves urinary symptoms in men with pre-treatment urinary complications

Primary prostate cancer treatment improves urinary symptoms in men with pre-treatment urinary complications

Posted by on Oct 9, 2016 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the benefits and drawbacks of prostate cancer treatment in patients who suffer from pre-treatment urinary problems. The authors concluded that patients with pre-treatment urinary problems benefitted from prostate surgery.  Some background Prostate surgery involves surgically removing the prostate...

Read More

Different radiation therapy schedules: Hyopfractioned EBRT is as effective as standard EBRT

Different radiation therapy schedules: Hyopfractioned EBRT is as effective as standard EBRT

Posted by on Oct 3, 2016 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for localized prostate cancer. Researchers reported no differences in survival or disease recurrence rates between high H-EBRT and EBRT. Some background Radiation therapy is a common treatment for localized...

Read More

Focal prostate radiotherapy in early prostate cancer

Focal prostate radiotherapy in early prostate cancer

Posted by on Sep 19, 2016 in Prostate cancer | 0 comments

In a nutshell The main objective of this study was to review all data available on focal radiotherapy (FRT) for men with early prostate cancer. The authors concluded that FRT was an option in early prostate cancer but may not be as effective in intermediate-risk tumors. Some background Radiation therapy is an important part of prostate cancer...

Read More

Does radiotherapy after lumpectomy improve survival rates in older women with ER- early-stage breast cancer?

Does radiotherapy after lumpectomy improve survival rates in older women with ER- early-stage breast cancer?

Posted by on Sep 12, 2016 in Breast cancer | 0 comments

In a nutshell This study investigated whether radiotherapy with lumpectomy (where only part of the breast is removed) in older women with estrogen receptor-negative (ER-) breast cancer would improve survival rates. For women over 70 years with ER- early-stage breast cancer, lumpectomy and radiotherapy improved overall survival rates and...

Read More

Is not undergoing surgery a safe treatment option in rectal cancer treatment?

Is not undergoing surgery a safe treatment option in rectal cancer treatment?

Posted by on Sep 5, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of rectal cancer patients with complete or near-complete response to chemotherapy and radiation therapy (CRT) who do not undergo surgery. Researchers reported that not undergoing surgery, in selected patients, is a safe option for treatment of rectal cancer.  Some background The standard...

Read More

Hormone therapy may shorten survival in African American men with low- or intermediate-risk prostate cancer

Hormone therapy may shorten survival in African American men with low- or intermediate-risk prostate cancer

Posted by on Aug 13, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the effect of ethnicity on health outcomes with androgen deprivation therapy (ADT). Researchers reported shorter survival among African American men receiving ADT for low- or intermediate-risk prostate cancer compared to men of other ethnicities. Some background ADT is a type of hormone therapy used to treat...

Read More

Evaluation of the probability of melanoma-specific mortality and non-cancer mortality

Evaluation of the probability of melanoma-specific mortality and non-cancer mortality

Posted by on Aug 8, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the probability of melanoma-specific mortality and mortality by other causes in melanoma patients. Researchers suggested that an individualized study of each patient probability helps treatment-related decision making. Some background The majority of patients with non-metastatic (spread to other parts of the...

Read More